13F HOLDINGS REPORT
Fairmount Funds Management LLC
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001104659-24-089572
Total Value
$885.1M
Positions
13
Other Managers
0
Confidential Omitted
No
Holdings (13)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | AXSOME THERAPEUTICS INC | AXSM | 2,360,077 | $190.0M | 21.46% |
| 2 | NUVALENT INC | NUVL | 1,924,626 | $146.0M | 16.50% |
| 3 | SPYRE THERAPEUTICS INC | SYRE | 4,018,101 | $94.5M | 10.67% |
| 4 | APOGEE THERAPEUTICS INC | APGE | 2,048,647 | $80.6M | 9.11% |
| 5 | ENLIVEN THERAPEUTICS INC | ELVN | 3,202,798 | $74.8M | 8.46% |
| 6 | DIANTHUS THERAPEUTICS INC | DNTH | 2,762,837 | $71.5M | 8.08% |
| 7 | KINIKSA PHARMACEUTICALS INTL | G52694109 | 3,204,841 | $59.8M | 6.76% |
| 8 | COGENT BIOSCIENCES INC | COGT | 6,225,641 | $52.5M | 5.93% |
| 9 | ASTRIA THERAPEUTICS INC | 04635X102 | 3,554,129 | $32.3M | 3.65% |
| 10 | PROTAGONIST THERAPEUTICS INC | PTGX | 931,890 | $32.3M | 3.65% |
| 11 | VIRIDIAN THERAPEUTICS INC | VRDN | 1,845,813 | $24.0M | 2.71% |
| 12 | BICYCLE THERAPEUTICS PLC | BCYC | 1,069,199 | $21.6M | 2.44% |
| 13 | TERNS PHARMACEUTICALS INC | TERN | 748,996 | $5.1M | 0.58% |